67 related articles for article (PubMed ID: 3052801)
1. Liver microsomal inactivation of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone as an inhibitor of ribonucleotide reductase.
Williams MT; Simonet L; Cory AH; Cory JG
Cancer Res; 1988 Nov; 48(22):6375-8. PubMed ID: 3052801
[TBL] [Abstract][Full Text] [Related]
2. Characterization of mouse leukemia L1210 cells resistant to the ribonucleotide reductase inhibitor 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
Cory AH; Sato A; Thompson DP; Cory JG
Oncol Res; 1996; 8(10-11):449-56. PubMed ID: 9114437
[TBL] [Abstract][Full Text] [Related]
3. 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone series.
Agrawal KC; Schenkman JB; Denk H; Mooney PD; Moore EC; Wodinsky I; Sartorelli AC
Cancer Res; 1977 Jun; 37(6):1692-6. PubMed ID: 870183
[TBL] [Abstract][Full Text] [Related]
4. Effects of the ferrous chelate of 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIQ-1) on the kinetics of reduction of CDP by ribonucleotide reductase of the Novikoff tumor.
Preidecker PJ; Agrawal KC; Sartorelli AC; Moore EC
Mol Pharmacol; 1980 Nov; 18(3):507-12. PubMed ID: 7007866
[No Abstract] [Full Text] [Related]
5. Herpes simplex type 1 ribonucleotide reductase. Mechanism studies with inhibitors.
Spector T; Jones TE
J Biol Chem; 1985 Jul; 260(15):8694-7. PubMed ID: 2991215
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibitors directed at the individual components of ribonucleotide reductase as an approach to combination chemotherapy.
Cory JG; Fleischer AE
Cancer Res; 1979 Nov; 39(11):4600-4. PubMed ID: 498090
[TBL] [Abstract][Full Text] [Related]
7. Mouse leukemia L1210 cells selected for resistance to the ribonucleotide reductase inhibitor, 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone show altered response to DNA damaging agents.
Crenshaw TR; Cory JG
Int J Oncol; 1999 Sep; 15(3):487-90. PubMed ID: 10427129
[TBL] [Abstract][Full Text] [Related]
8. Herpes simplex virus ribonucleotide reductase induced in infected BHK-21/C13 cells: biochemical evidence for the existence of two non-identical subunits, H1 and H2.
Cohen EA; Charron J; Perret J; Langelier Y
J Gen Virol; 1985 Apr; 66 ( Pt 4)():733-45. PubMed ID: 2984316
[TBL] [Abstract][Full Text] [Related]
9. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
Weber GF; Waxman DJ
Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the NADPH-dependent covalent binding of [14C]halothane to human liver microsomes: a role for cytochrome P4502E1 at low substrate concentrations.
Madan A; Parkinson A
Drug Metab Dispos; 1996 Dec; 24(12):1307-13. PubMed ID: 8971135
[TBL] [Abstract][Full Text] [Related]
11. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
[TBL] [Abstract][Full Text] [Related]
12. Relationships between sensitivity to hydroxyurea and 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone (MAIO) and ribonucleotide reductase RNR2 mRNA levels in strains of Saccharomyces cerevisiae.
Rittberg DA; Wright JA
Biochem Cell Biol; 1989 Jul; 67(7):352-7. PubMed ID: 2675933
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
14. Lack of mechanism-based inactivation of rat hepatic microsomal cytochromes P450 by doxorubicin.
Di Re J; Lee C; Riddick DS
Can J Physiol Pharmacol; 1999 Aug; 77(8):589-97. PubMed ID: 10543722
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of combinations of drugs that inhibit Ehrlich tumor cell ribonucleotide reductase.
Sato A; Cory JG
Cancer Res; 1981 May; 41(5):1637-41. PubMed ID: 6783298
[TBL] [Abstract][Full Text] [Related]
16. Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate.
Masubuchi Y; Igarashi S; Suzuki T; Horie T; Narimatsu S
J Pharmacol Exp Ther; 1996 Nov; 279(2):724-31. PubMed ID: 8930177
[TBL] [Abstract][Full Text] [Related]
17. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
18. Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine.
Kaul KL; Novak RF
J Pharmacol Exp Ther; 1987 Oct; 243(1):384-90. PubMed ID: 3668864
[TBL] [Abstract][Full Text] [Related]
19. Altered efflux properties of mouse leukemia L1210 cells resistant to 4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone.
Cory JG; Cory AH; Lorico A; Rappa G; Sartorelli AC
Anticancer Res; 1997; 17(5A):3185-93. PubMed ID: 9413147
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
Grubb MF; Diamond S; Christ DD
Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]